Marsha Fanucci, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 10,000 shares at $104.83 ($1.1M) on 2015-02-25, disclosed to the SEC on 2015-02-27.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.83 | 3,654 | $383K | 36.2% |
| 2 | $105.66 | 2,621 | $277K | 26.2% |
| 3 | $106.72 | 3,025 | $323K | 30.5% |
| 4 | $107.36 | 700 | $75K | 7.1% |
| Total | $105.80 avg | 10,000 | $1.1M | 100% |
| Filing → |
| MNTA | SELL | 2013-03-18 | $416K | — | Filing → |
| ALNY | BUY | 2012-02-23 | $108K | — | Filing → |
| IRWD | BUY | 2010-02-04 | $248K | — | Filing → |